[CEO Story]BioCentury-BayHelix China Healthcare Summit 2021

8 Nov 2021
TitleBioCentury-BayHelix China Healthcare Summit 2021
CategoryCEO Story 

BioCentury-BayHelix China Healthcare Summit 2021

PharmAbcine, a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to present at BioCentury-BayHelix China Healthcare Summit 2021 from November 16 – 19, 2021.

At the event, Dr. Yoo will introduce PharmAbcine’s key antibody drug candidates, such as Olinvacimab, PMC-309, and PMC-403, and seek potential licensing deals and co-development opportunities.

Also, an online session video featuring Dr. Jin-San Yoo and other key members from Korean biotechs will be available during the event. The session’s main topic will be focused on potential collaboration opportunities between biotechs.

■ Visit the link below to register for the event.


■ Visit the link below for the list of key speakers presenting at this event.


     2F, Research Building 2, 70,

     Yuseong-daero 1689 beon-gil,
     Yuseong-gu, Daejeon, 34047, Republic of Korea

     HQ +82-42-863-2017 

     R&D Center +82-42-861-2017

     Investor Relations +70-4294-6097 

     FAX +82-42-863-2080 

     COPYRIGHT BY PharmAbcine Inc.